Unity BiotechnologyUNBX

13F holders, Q3 2024 (September 30)
38holders −1
6new positions
7sold out
2famous investors
$1.47avg. 13F price*

At the end of Q3 2024, 38 institutions reported holding Unity Biotechnology Inc. (UNBX) in their 13F filings, down 1 from Q2 2024. 6 opened new positions and 7 sold out. The largest holders were ARCH Venture Management, LLC ($1.5M), Alyeska Investment Group, L.P. ($1.4M) and Vanguard Group Inc. ($868K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).

Company
Unity Biotechnology Inc.
CUSIP
91381U200
Latest filing quarter
Q3 2025

History

Number of 13F holders

010203040 Q1 2024: 40Q1 2024Q2 2024: 39Q2 2024Q3 2024: 38Q3 2024Q4 2024: 37Q4 2024Q1 2025: 40Q1 2025Q2 2025: 35Q2 2025Q3 2025: 6Q3 2025

Total Exit/New Position Q2 2024 → Q3 2024

InstitutionsTotal Value
New Positions6$85K
Exits7$39K

All 13F filers, Q2 2024 → Q3 2024: 108,538 shares bought and 91,668 shares sold, net +16,870 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.

Ownership 38 holders

ARCH Venture Management, LLC 0.57% No change 1,004,817 $1.5M
Alyeska Investment Group, L.P. 0.01% No change 920,013 $1.4M
Vanguard Group Inc. 0.00% No change 590,770 $868K
Geode Capital Management, LLC 0.00% Add +9.5% 163,242 $240K
Mayo Clinic 6.29% No change 124,081 $182K
Renaissance Technologies 0.00% Add +45.0% 93,670 $138K
BlackRock, Inc. 0.00% — 81,174 $119K
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 0.00% Add +10.2% 79,354 $117K
Citadel Advisors 0.00% Reduce -4.2% 69,210 $102K
Ballentine Partners, LLC 0.00% New 57,046 $84K
Founders Fund V Management, LLC 12.64% No change 49,172 $72K
Morgan Stanley 0.00% Reduce -16.0% 44,691 $66K
Cercano Management LLC 0.00% No change 41,238 $61K
State Street Corp. 0.00% No change 37,824 $56K
Bridgeway Capital Management, LLC 0.00% No change 25,000 $37K
Commonwealth Equity Services, LLC 0.00% Reduce -2.0% 24,112 $35K
Northern Trust Corp. 0.00% No change 22,549 $33K
Endowment Wealth Management, Inc. 0.01% No change 13,495 $20K
Osaic Holdings, Inc. 0.00% Reduce -12.3% 11,463 $17K
Tower Research Capital LLC (TRC) 0.00% Reduce -57.1% 2,059 $3K
Steward Partners Investment Advisory, LLC 0.00% Reduce -42.9% 2,000 $3K
Glen Eagle Advisors, LLC 0.00% No change 1,104 $2K
Cwm, LLC 0.00% No change 500 $1K
UBS Group AG 0.00% New 387 $569
Whittier Trust Co. 0.00% New 360 $529
JPMorgan Chase & Co. 0.00% Reduce -65.3% 272 $400
Activest Wealth Management 0.00% No change 200 $294
Signaturefd, LLC 0.00% No change 200 $294
Bank of America Corp. 0.00% Add +0.8% 126 $185
Carmichael Hill & Associates, Inc. 0.00% No change 100 $147
Ameritas Investment Partners, Inc. 0.00% No change 100 $147
Wells Fargo & Company 0.00% Reduce -99.9% 61 $90
AllSquare Wealth Management LLC 0.00% No change 55 $81
Jaffetilchin Investment Partners, LLC 0.00% New 50 $74
Jones Financial Companies LLLP 0.00% New 26 $38
HHM Wealth Advisors, LLC 0.00% No change 25 $37
FMR LLC 0.00% New 10 $15
Royal Bank of Canada 0.00% Reduce -69.3% 120 $0

"% of holder's portfolio" is UNBX's weight in each manager's 13F, not the share of Unity Biotechnology Inc. the manager owns.